Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Stem Cell Research

  Free Subscription


Articles published in Bone Marrow Transplant

Retrieve available abstracts of 323 articles:
HTML format



Single Articles


    August 2022
  1. HANNA P, Strohbehn I, Moreno D, Harden D, et al
    Comparison of short- and long-term adverse kidney outcomes after chimeric antigen receptor T cell therapy and autologous hematopoietic stem cell transplant for diffuse large B cell lymphoma.
    Bone Marrow Transplant. 2022 Aug 3. pii: 10.1038/s41409-022-01767.
    PubMed    


  2. KANG KR, Kim YJ, Ahn MB, Kang HM, et al
    Shorter duration of protection and lower geometric mean titers against A/H3N2 antigen of the quadrivalent influenza vaccine in children post-allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2022 Aug 1. pii: 10.1038/s41409-022-01768.
    PubMed    


    July 2022
  3. MA J, Sun S, Hu Y, Wu M, et al
    Novel conditioning regimen in upfront autologous stem cell transplantation in high-risk DLBCL.
    Bone Marrow Transplant. 2022 Jul 25. pii: 10.1038/s41409-022-01766.
    PubMed    


  4. PRABAHRAN A, Koldej R, Chee L, Szer J, et al
    Non-relapse cytopenias following allogeneic stem cell transplantation, a case based review.
    Bone Marrow Transplant. 2022 Jul 23. pii: 10.1038/s41409-022-01761.
    PubMed     Abstract available


  5. BUSCA A, Gabrielli G, Sidoti F, Costa C, et al
    SARS-CoV-2 infection in a stem cell transplant recipient grafted from a SARS-CoV-2-positive donor.
    Bone Marrow Transplant. 2022 Jul 16. pii: 10.1038/s41409-022-01763.
    PubMed    


  6. ZU Y, Li Z, Gui R, Liu Y, et al
    Low-dose post-transplant cyclophosphamide with low-dose antithymocyte globulin for prevention of graft-versus-host disease in first complete remission undergoing 10/10 HLA-matched unrelated donor peripheral blood stem cell transplants: a multicentre,
    Bone Marrow Transplant. 2022 Jul 15. pii: 10.1038/s41409-022-01754.
    PubMed     Abstract available


  7. DE KLOET LC, Bense JE, van der Stoep MYEC, Louwerens M, et al
    Late endocrine effects after hematopoietic stem cell transplantation in children with nonmalignant diseases.
    Bone Marrow Transplant. 2022 Jul 15. pii: 10.1038/s41409-022-01755.
    PubMed     Abstract available


  8. MERLI P, Massa M, Russo A, Rea F, et al
    Fecal microbiota transplantation for the treatment of steroid-refractory, intestinal, graft-versus-host disease in a pediatric patient.
    Bone Marrow Transplant. 2022 Jul 14. pii: 10.1038/s41409-022-01752.
    PubMed    


  9. MASSOUD R, Klyuchnikov E, Gagelmann N, Zabelina T, et al
    Impact of Anti-T-lymphocyte globulin dosing on GVHD and Immune reconstitution in matched unrelated myeloablative peripheral blood stem cell transplantation.
    Bone Marrow Transplant. 2022 Jul 13. pii: 10.1038/s41409-022-01666.
    PubMed     Abstract available


  10. JAMY O, Arora S, Meredith R, Salzman D, et al
    Phase II study of myeloablative allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia in adults using fludarabine and total body irradiation 12 Gy.
    Bone Marrow Transplant. 2022 Jul 9. pii: 10.1038/s41409-022-01757.
    PubMed    


  11. TSAMADOU C, Gowdavally S, Platzbecker U, Sala E, et al
    Donor genetic determinant of thymopoiesis rs2204985 impacts clinical outcome after single HLA mismatched hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2022 Jul 8. pii: 10.1038/s41409-022-01751.
    PubMed     Abstract available


  12. JACOBS JW, Adkins BD, Wheeler AP, Booth GS, et al
    Diversity, equity, and inclusion in transfusion medicine, blood donation, and blood and bone marrow transplantation: language matters.
    Bone Marrow Transplant. 2022 Jul 8. pii: 10.1038/s41409-022-01758.
    PubMed    


  13. HASHMI S, Ram R
    The great Lazar-a Graft-versus-host-disease patient!
    Bone Marrow Transplant. 2022 Jul 8. pii: 10.1038/s41409-022-01707.
    PubMed    


  14. RANGARAJAN HG, Crowell SA, Towerman AS, Shenoy SS, et al
    CD34-selected stem cell boost as therapy for late graft rejection following allogeneic transplantation for sickle cell disease.
    Bone Marrow Transplant. 2022 Jul 7. pii: 10.1038/s41409-022-01749.
    PubMed    


  15. MARCAIS A, Mahlaoui N, Neven B, Lanternier F, et al
    Curative allogeneic hematopoietic stem cell transplantation following reduced toxicity conditioning in adults with primary immunodeficiency.
    Bone Marrow Transplant. 2022 Jul 6. pii: 10.1038/s41409-022-01739.
    PubMed     Abstract available


  16. YINGLING SK, Gonzalez RM, Dillaman M, Seago K, et al
    Impact of body mass index (BMI) on the efficacy of plerixafor for hematopoietic progenitor cell (HPC) mobilization.
    Bone Marrow Transplant. 2022;57:1194-1197.
    PubMed    


  17. DING L, Han DM, Yan HM, Zhou JX, et al
    Infusion of haploidentical HSCs combined with allogenic MSCs for the treatment of ALL patients.
    Bone Marrow Transplant. 2022;57:1086-1094.
    PubMed     Abstract available


    June 2022
  18. NAGLER A, Labopin M, Cornelissen JJ, Forcade E, et al
    Outcome of human umbilical cord blood stem cell transplantation (CBT) for acute myeloid leukemia in patients achieving first complete remission after one versus two induction courses: a study from the Acute Leukemia Working Party of the European Socie
    Bone Marrow Transplant. 2022 Jun 30. pii: 10.1038/s41409-022-01742.
    PubMed     Abstract available


  19. LE BRIS Y, Costes D, Bourgade R, Guillaume T, et al
    Impact on outcomes of mixed chimerism of bone marrow CD34+ sorted cells after matched or haploidentical allogeneic stem cell transplantation for myeloid malignancies.
    Bone Marrow Transplant. 2022 Jun 28. pii: 10.1038/s41409-022-01747.
    PubMed     Abstract available


  20. SELVARAJAN S, Tammiraju S, Lionel S, Kulkarni U, et al
    Cyclophosphamide induced haemorrhagic myocarditis-pericarditis: a rare but lethal complication in the setting of allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2022 Jun 27. pii: 10.1038/s41409-022-01745.
    PubMed    


  21. LEMAIRE B, Combescure C, Chalandon Y, Vuilleumier N, et al
    Kinetics of disappearance and appearance of isoagglutinins A and B after ABO-incompatible hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2022 Jun 25. pii: 10.1038/s41409-022-01737.
    PubMed     Abstract available


  22. HOLTAN SG, Yu J, Paranagama D, Tang J, et al
    Disease progression, hospital readmissions, and clinical outcomes for patients with steroid-refractory acute graft-versus-host disease: A multicenter, retrospective study.
    Bone Marrow Transplant. 2022 Jun 23. pii: 10.1038/s41409-022-01736.
    PubMed     Abstract available


  23. TANG L, Wu Y, Lei R, Liu J, et al
    Adding 5-day decitabine to the conditioning regimen for haploidentical bone marrow transplantation in aplastic anaemia patients results in satisfactory clinical outcomes.
    Bone Marrow Transplant. 2022 Jun 22. pii: 10.1038/s41409-022-01729.
    PubMed    


  24. PEROVIC V, Sabol I, Grce M, Inngjerdingen M, et al
    Practice patterns in chronic graft-versus-host disease patient management and patient reported outcome measures across the EBMT allogeneic transplantation network.
    Bone Marrow Transplant. 2022 Jun 11. pii: 10.1038/s41409-022-01733.
    PubMed    


  25. LAZZARI L, Balaguer-Rosello A, Montoro J, Greco R, et al
    Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia.
    Bone Marrow Transplant. 2022 Jun 9. pii: 10.1038/s41409-022-01725.
    PubMed     Abstract available


  26. SONG Y, Chen S, Roseman J, Scigliano E, et al
    Patient-generated strategies for strengthening adherence to multiple medication regimens after allogeneic stem cell transplantation: a qualitative study.
    Bone Marrow Transplant. 2022 Jun 9. pii: 10.1038/s41409-022-01727.
    PubMed    


  27. LIU Y, Duan Z, Li F, Zhang X, et al
    Acute kidney injury in peripheral blood haploidentical hematopoietic stem cell transplantation: should attract enough attention.
    Bone Marrow Transplant. 2022 Jun 7. pii: 10.1038/s41409-022-01731.
    PubMed    


  28. ELHADAD S, Chadburn A, Magro C, Van Besien K, et al
    C5b-9 and MASP2 deposition in skin and bone marrow microvasculature characterize hematopoietic stem cell transplant-associated thrombotic microangiopathy.
    Bone Marrow Transplant. 2022 Jun 4. pii: 10.1038/s41409-022-01723.
    PubMed    


  29. TAMAKI M, Matsumi S, Nakasone H, Nakamura Y, et al
    Interstitial lung disease with anti-melanoma differentiation-associated gene 5 antibody after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2022 Jun 4. pii: 10.1038/s41409-022-01730.
    PubMed     Abstract available


  30. HANNA P, Strohbehn I, Wang Q, Frigault M, et al
    Acute kidney injury caused by haplostorm after allogenic hematopoietic stem cell transplant.
    Bone Marrow Transplant. 2022 Jun 4. pii: 10.1038/s41409-022-01720.
    PubMed    


  31. RUESCH M, Amar El Dusouqui S, Buhrfeind E, Buser A, et al
    Basic characteristics and safety of donation in related and unrelated haematopoietic progenitor cell donors - first 10 years of prospective donor follow-up of Swiss donors.
    Bone Marrow Transplant. 2022;57:918-924.
    PubMed     Abstract available


    May 2022
  32. PESSOA JM, da Rosa EL, Americo AD, Motta CL, et al
    Cryopreserved versus non-cryopreserved stem cell autografts in multiple myeloma a restrospective cohort study.
    Bone Marrow Transplant. 2022 May 30. pii: 10.1038/s41409-022-01718.
    PubMed     Abstract available


  33. WELLS JR, Kang G, Suliman AY, Li Y, et al
    Delayed platelet recovery and mortality after allogeneic stem cell transplantation in children.
    Bone Marrow Transplant. 2022 May 28. pii: 10.1038/s41409-022-01726.
    PubMed    


  34. NISHIDA M, Sugita J, Iwai T, Sato M, et al
    Ultrasonographic scoring system of late-onset sinusoidal obstruction syndrome/veno-occlusive disease after hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2022 May 25. pii: 10.1038/s41409-022-01717.
    PubMed    


  35. FERNANDEZ-SOJO J, Cid J, Azqueta C, Valdivia E, et al
    Post thawing viable CD34+ Cells dose is a better predictor of clinical outcome in lymphoma patients undergoing autologous stem cell transplantation.
    Bone Marrow Transplant. 2022 May 25. pii: 10.1038/s41409-022-01722.
    PubMed    


  36. ANDERSSON BS, Thall PF, Ma J, Valdez BC, et al
    A randomized phase III study of pretransplant conditioning for AML/MDS with fludarabine and once daily IV busulfan +/- clofarabine in allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2022 May 24. pii: 10.1038/s41409-022-01705.
    PubMed     Abstract available


  37. LINGBLOM C, Andersson K, Johansson JE, Wenneras C, et al
    Multivariate modeling of eosinophil markers and other cellular immune parameters associated with the development of chronic graft-versus-host disease.
    Bone Marrow Transplant. 2022 May 23. pii: 10.1038/s41409-022-01708.
    PubMed    


  38. ANGELOV D, Dillon J, Mellerick L, Pender E, et al
    Allogeneic transplantation in Cutaneous T-cell Lymphoma: improved outcomes associated with early transplantation and acute graft versus host disease.
    Bone Marrow Transplant. 2022 May 20. pii: 10.1038/s41409-022-01713.
    PubMed    


  39. AMONOO HL, Harnedy LE, Deary EC, Traeger L, et al
    Peer support in patients with hematologic malignancies undergoing hematopoietic stem cell transplantation (HSCT): a qualitative study.
    Bone Marrow Transplant. 2022 May 19. pii: 10.1038/s41409-022-01711.
    PubMed     Abstract available


  40. ALEXANDER T, Greco R
    Hematopoietic stem cell transplantation and cellular therapies for autoimmune diseases: overview and future considerations from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT).
    Bone Marrow Transplant. 2022 May 16. pii: 10.1038/s41409-022-01702.
    PubMed     Abstract available


  41. KUSKONMAZ B, Ayvaz D, Okur FV, Aydin B, et al
    First allogeneic hematopoietic stem cell transplantation in RASGRP1 deficiency: long-term follow-up.
    Bone Marrow Transplant. 2022 May 14. pii: 10.1038/s41409-022-01704.
    PubMed    


  42. DANYLESKO I, Peczynski C, Labopin M, Polge E, et al
    Impact of donor kinship on non-T-cell depleted haploidentical stem cell transplantation with post transplantation cyclophosphamide for acute leukemia: From the ALWP of the EBMT.
    Bone Marrow Transplant. 2022 May 13. pii: 10.1038/s41409-022-01695.
    PubMed     Abstract available


  43. FRIETSCH JJ, Miethke J, Linke P, Crodel CC, et al
    Treosulfan plus fludarabine versus TEAM as conditioning treatment before autologous stem cell transplantation for B-cell Non-Hodgkin lymphoma.
    Bone Marrow Transplant. 2022 May 10. pii: 10.1038/s41409-022-01701.
    PubMed     Abstract available


  44. PENGLASE R, Englert H, Tymms K, Carr A, et al
    Successful lymphoablative autologous haematopoietic stem cell transplantation in three cases of severe autoimmune disease despite reduced dose cyclophosphamide conditioning-do we need 200 mg/kg cyclophosphamide?
    Bone Marrow Transplant. 2022 May 6. pii: 10.1038/s41409-022-01696.
    PubMed    


  45. WIECZOREK M, Mariotto S, Ferrari S, Mosna F, et al
    Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: Incidence, characteristics and long-term follow-up in a multicenter series.
    Bone Marrow Transplant. 2022 May 5. pii: 10.1038/s41409-022-01690.
    PubMed     Abstract available


  46. OHASHI T, Aoki J, Ando T, Ishiyama Y, et al
    Clinical impact of cigarette smoking on the outcomes of allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study.
    Bone Marrow Transplant. 2022 May 3. pii: 10.1038/s41409-022-01678.
    PubMed     Abstract available


  47. WADA F, Kondo T, Yamamoto R, Yamagiwa T, et al
    Addition and drug monitoring of mycophenolate mofetil for GVHD prophylaxis in unrelated bone marrow transplantation.
    Bone Marrow Transplant. 2022 May 2. pii: 10.1038/s41409-022-01692.
    PubMed    


    April 2022
  48. AL SALEH AS, Alghamdi AI, Alzahrani M, Alahmari B, et al
    Rates and predictors of infusion-related reactions in patients receiving standard versus prolonged infusion of rabbit anti-thymocyte globulin for hematopoietic stem cell transplantation, a retrospective analysis.
    Bone Marrow Transplant. 2022 Apr 30. pii: 10.1038/s41409-022-01694.
    PubMed    


  49. LIANG H, Pan L, Xie Y, Fan J, et al
    Health-related quality of life in pediatric patients with beta-thalassemia major after hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2022 Apr 29. pii: 10.1038/s41409-022-01663.
    PubMed     Abstract available


  50. NAWAS MT, Lee JO, Flynn J, Maloy M, et al
    CD34+ -selected hematopoietic stem cell transplant conditioned with a myeloablative regimen in patients with advanced myelofibrosis.
    Bone Marrow Transplant. 2022 Apr 28. pii: 10.1038/s41409-022-01684.
    PubMed     Abstract available


  51. SOLA M, Bhatt V, Palazzo M, Cavalier KE, et al
    Low-dose unfractionated heparin prophylaxis is a safe strategy for the prevention of hepatic sinusoidal obstruction syndrome after myeloablative adult allogenic stem cell transplant.
    Bone Marrow Transplant. 2022 Apr 27. pii: 10.1038/s41409-022-01689.
    PubMed     Abstract available


  52. ZHANG R, Lu X, Tang LV, Wang HF, et al
    Comparative analysis of Decitabine intensified BUCY2 and BUCY2 conditioning regimen for high-risk MDS patients undergoing allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2022 Apr 22. pii: 10.1038/s41409-022-01645.
    PubMed     Abstract available


  53. NIEDERWIESER C, Weber B, Reichard M, Gagelmann N, et al
    Endothelial complications after allogeneic stem cell transplantation in patients with pretransplant resolved COVID-19.
    Bone Marrow Transplant. 2022 Apr 20. pii: 10.1038/s41409-022-01660.
    PubMed    


  54. DELIA M, Carluccio P, Gagliardi VP, Mestice A, et al
    Deciphering the effects of graft Tregs on chronic graft-versus-host disease: results from a prospective, multicenter study in patients with acute leukemia undergoing allogeneic peripheral blood stem cell transplantation.
    Bone Marrow Transplant. 2022 Apr 19. pii: 10.1038/s41409-022-01676.
    PubMed    


  55. SALHOTRA A, Talley M, Wu X, Tsai W, et al
    Clinical and immunologic responses to extracorporeal photopheresis and low-dose IL-2 in patients with steroid refractory chronic graft-versus host disease.
    Bone Marrow Transplant. 2022 Apr 19. pii: 10.1038/s41409-022-01671.
    PubMed    


  56. SCHROEDER MA, Hari PN, Blithe A, Paranagama D, et al
    Safety analysis of patients who received ruxolitinib for steroid-refractory acute or chronic graft-versus-host disease in an expanded access program.
    Bone Marrow Transplant. 2022 Apr 18. pii: 10.1038/s41409-022-01673.
    PubMed     Abstract available


  57. SCHENONE L, Houillier C, Tanguy ML, Choquet S, et al
    Intensive chemotherapy followed by autologous stem cell transplantation in primary central nervous system lymphomas (PCNSLs). Therapeutic outcomes in real life-experience of the French Network.
    Bone Marrow Transplant. 2022 Apr 14. pii: 10.1038/s41409-022-01648.
    PubMed     Abstract available


  58. LAZANA I, Floro L, Christmas T, Shah S, et al
    Autologous stem cell transplantation for multiple myeloma patients with chronic kidney disease: a safe and effective option.
    Bone Marrow Transplant. 2022 Apr 12. pii: 10.1038/s41409-022-01657.
    PubMed     Abstract available


  59. MASOOD A, Wahab A, Iqbal Q, Davis J, et al
    Efficacy and safety of allogeneic hematopoietic stem cell transplant in adults with hemophagocytic lymphohistiocytosis: a systematic review of literature.
    Bone Marrow Transplant. 2022 Apr 11. pii: 10.1038/s41409-022-01668.
    PubMed     Abstract available


  60. SHIPTON MJ, Kinsella PM, Davis T, Azzato F, et al
    Infective hyperammonaemic encephalopathy after allogeneic stem cell transplant.
    Bone Marrow Transplant. 2022 Apr 11. pii: 10.1038/s41409-022-01669.
    PubMed    


  61. JORIS MM, Schmidt AH, Bernas SN, Feinberg J, et al
    Impact of COVID-19 pandemic on global unrelated stem cell donations in 2020-Report from World Marrow Donor Association.
    Bone Marrow Transplant. 2022 Apr 9. pii: 10.1038/s41409-022-01667.
    PubMed    


  62. PIEVANI A, Granata V, Desantis G, Antolini L, et al
    CD14 positive cells accelerate hematopoietic stem cell engraftment.
    Bone Marrow Transplant. 2022 Apr 8. pii: 10.1038/s41409-022-01662.
    PubMed     Abstract available


  63. LIU H, Liu W, Li R, Jiao Y, et al
    A gemcitabine-based regimen followed by autologous stem cell transplantation show high efficacy and well tolerance in malignant lymphoma.
    Bone Marrow Transplant. 2022 Apr 7. pii: 10.1038/s41409-022-01655.
    PubMed    


  64. COOK J, Gonsalves WI, Gertz MA, Visram A, et al
    Success of the autologous stem cell boost after autologous graft failure in multiple myeloma and AL amyloidosis.
    Bone Marrow Transplant. 2022 Apr 2. pii: 10.1038/s41409-022-01659.
    PubMed    


  65. MCCANN SR
    Choices: peripheral blood or marrow: natural or cloned yeasts.
    Bone Marrow Transplant. 2022;57:524-525.
    PubMed    


    March 2022
  66. JANSSEN MJM, Bruns AHW, Verduyn Lunel FM, Raijmakers RAP, et al
    Correction to: Predictive factors for vaccine failure to guide vaccination in allogeneic hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2022 Mar 31. pii: 10.1038/s41409-022-01651.
    PubMed    


  67. SCHNEIDEWIND L, Neumann T, Peters N, Kranz J, et al
    Significance of men's health in long-term survivors of allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2022 Mar 25. pii: 10.1038/s41409-022-01638.
    PubMed    


  68. MACHOWICZ R, Suarez F, Wiktor-Jedrzejczak W, Eikema DJ, et al
    Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMT.
    Bone Marrow Transplant. 2022 Mar 24. pii: 10.1038/s41409-022-01634.
    PubMed     Abstract available


  69. JIANG JL, Chen M, Wang LN, Wan M, et al
    Double alkylators based conditioning reduced the relapse rate after allogeneic peripheral blood stem cell transplantation in adult patients with myeloid malignancies: a single arm phase II study.
    Bone Marrow Transplant. 2022 Mar 24. pii: 10.1038/s41409-022-01643.
    PubMed    


  70. ANDRE I, Simons L, Ma K, Moirangthem RD, et al
    Correction to: Ex vivo generated human T-lymphoid progenitors as a tool to accelerate immune reconstitution after partially HLA compatible hematopoietic stem cell transplantation or after gene therapy.
    Bone Marrow Transplant. 2022 Mar 16. pii: 10.1038/s41409-022-01629.
    PubMed    


  71. KARAM D, Gertz M, Lacy M, Dispenzieri A, et al
    Impact of maintenance therapy post autologous stem cell transplantation for multiple myeloma in early and delayed transplant.
    Bone Marrow Transplant. 2022 Mar 16. pii: 10.1038/s41409-022-01631.
    PubMed     Abstract available


  72. UENO T, Ohta T, Sugio Y, Ohno Y, et al
    Severe acute interstitial lung disease after BNT162b2 mRNA COVID-19 vaccination in a patient post HLA-haploidentical hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2022 Mar 10. pii: 10.1038/s41409-022-01633.
    PubMed    


  73. GALLI E, Sora F, Hohaus S, Bellesi S, et al
    Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma.
    Bone Marrow Transplant. 2022 Mar 8. pii: 10.1038/s41409-022-01632.
    PubMed    


  74. PAHNKE S, Nygell UA, Johansson JE, Kisch A, et al
    Cancer incidence in healthy Swedish peripheral blood stem cell donors.
    Bone Marrow Transplant. 2022 Mar 7. pii: 10.1038/s41409-022-01617.
    PubMed     Abstract available


  75. EL JURDI N, Okoev G, DeFor TE, Holtan SG, et al
    Predictors and outcomes of flares in chronic graft-versus-host disease.
    Bone Marrow Transplant. 2022 Mar 5. pii: 10.1038/s41409-022-01628.
    PubMed     Abstract available


    February 2022
  76. ZHANG Z, Hasegawa Y, Hashimoto D, Senjo H, et al
    Gilteritinib enhances graft-versus-leukemia effects against FLT3-ITD mutant leukemia after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2022 Feb 28. pii: 10.1038/s41409-022-01619.
    PubMed     Abstract available


  77. FORCADE E, Chevret S, Finke J, Ehninger G, et al
    Impact of in vivo T-cell depletion in patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplant: a registry study from the Chronic Malignancies Working Party of the EBMT.
    Bone Marrow Transplant. 2022 Feb 26. pii: 10.1038/s41409-022-01620.
    PubMed     Abstract available


  78. YESILIPEK MA, Uygun V, Kupesiz A, Karasu G, et al
    Thalassemia-free and graft-versus-host-free survival: outcomes of hematopoietic stem cell transplantation for thalassemia major, Turkish experience.
    Bone Marrow Transplant. 2022 Feb 24. pii: 10.1038/s41409-022-01613.
    PubMed     Abstract available


  79. LINDAHL H, Vonlanthen S, Valentini D, Bjorklund AT, et al
    Lineage-specific early complete donor chimerism and risk of relapse after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia.
    Bone Marrow Transplant. 2022 Feb 24. pii: 10.1038/s41409-022-01615.
    PubMed     Abstract available


  80. ARSLAN S, Ali H, Mei M, Marcucci G, et al
    Successful treatment of refractory pure red cell aplasia in major ABO-mismatched allogeneic hematopoietic stem cell transplant with single agent Ibrutinib.
    Bone Marrow Transplant. 2022 Feb 22. pii: 10.1038/s41409-022-01590.
    PubMed    


  81. HUTT D, Arjona ET, Mekelenkamp H, Galimard JE, et al
    Safe transfer of pediatric patients from hematopoietic stem cell transplant unit into the pediatric intensive care unit: views of nurses and physicians.
    Bone Marrow Transplant. 2022 Feb 21. pii: 10.1038/s41409-021-01559.
    PubMed     Abstract available


  82. MADANCHI R, Engel NW, Alsdorf W, Oing C, et al
    Approaches of stem cell mobilization in a large cohort of metastatic germ cell cancer patients.
    Bone Marrow Transplant. 2022 Feb 21. pii: 10.1038/s41409-022-01614.
    PubMed     Abstract available


  83. MORENO-CASTANO AB, Palomo M, Torramade-Moix S, Martinez-Sanchez J, et al
    An endothelial proinflammatory phenotype precedes the development of the engraftment syndrome after autologous Hct.
    Bone Marrow Transplant. 2022 Feb 18. pii: 10.1038/s41409-022-01610.
    PubMed     Abstract available


  84. LEIMI L, Jahnukainen K, Olkinuora H, Meri S, et al
    Early vascular toxicity after pediatric allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2022 Feb 17. pii: 10.1038/s41409-022-01607.
    PubMed     Abstract available


  85. YOON SE, Jo H, Kang ES, Cho D, et al
    Role of upfront autologous stem cell transplantation in patients newly diagnosed with primary CNS lymphoma treated with R-MVP: real-world data from a retrospective single-center analysis.
    Bone Marrow Transplant. 2022 Feb 16. pii: 10.1038/s41409-022-01605.
    PubMed     Abstract available


  86. DROZDOV D, Petermann K, Dougoud S, Oberholzer S, et al
    Dynamics of recent thymic emigrants in pediatric recipients of allogeneic hematopoetic stem cell transplantation.
    Bone Marrow Transplant. 2022 Feb 9. pii: 10.1038/s41409-022-01594.
    PubMed     Abstract available


  87. SUH JK, Im HJ, Kang SH, Kim H, et al
    Treosulfan-based conditioning regimen for allogeneic hematopoietic stem cell transplantation in children with non-malignant diseases.
    Bone Marrow Transplant. 2022 Feb 7. pii: 10.1038/s41409-021-01556.
    PubMed    


  88. PIEMONTESE S, Lazzari L, Ruggeri A, Marcatti M, et al
    Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experience.
    Bone Marrow Transplant. 2022 Feb 5. pii: 10.1038/s41409-022-01600.
    PubMed    


  89. GEVORGIAN AG, Kozlov AV, Tolkunova PS, Kazantzev IV, et al
    Tandem autologous hematopoietic stem cell transplantation for embryonal brain tumors in infants and very young children.
    Bone Marrow Transplant. 2022 Feb 3. pii: 10.1038/s41409-022-01593.
    PubMed     Abstract available


  90. PARSONS SK, Rodday AM, Weidner RA, Morris E, et al
    Significant improvement of child physical and emotional functioning after familial haploidentical stem cell transplant.
    Bone Marrow Transplant. 2022 Feb 2. pii: 10.1038/s41409-022-01584.
    PubMed     Abstract available


  91. LINDHOLM C, Olofsson E, Creignou M, Nilsson L, et al
    Failure to reach hematopoietic allogenic stem cell transplantation in patients with myelodysplastic syndromes planned for transplantation: a population-based study.
    Bone Marrow Transplant. 2022 Feb 2. pii: 10.1038/s41409-022-01582.
    PubMed     Abstract available


  92. FRIEND BD, Muhsen IN, Patel S, Hill LC, et al
    Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphoma.
    Bone Marrow Transplant. 2022 Feb 1. pii: 10.1038/s41409-022-01599.
    PubMed     Abstract available


  93. NAGLER A, Labopin M, Huang XJ, Blaise D, et al
    Non-T depleted haploidentical stem cell transplantation in AML patients achieving first complete remission after one versus two induction courses: a study from the ALWP/EBMT.
    Bone Marrow Transplant. 2022 Feb 1. pii: 10.1038/s41409-021-01537.
    PubMed     Abstract available


    January 2022
  94. FILE B, Huang Y, Peedin A, Gergis U, et al
    The impact of HLA donor-specific antibodies on engraftment and the evolving desensitization strategies.
    Bone Marrow Transplant. 2022 Jan 26. pii: 10.1038/s41409-022-01578.
    PubMed     Abstract available


  95. SKEENS M, Guttoo P, Stanek JR, Taylor K, et al
    An Exploration of COVID-19 Impact and Vaccine Hesitancy in Parents of Pediatric Hematopoietic Stem Cell Transplant (HCT) Recipients.
    Bone Marrow Transplant. 2022 Jan 24. pii: 10.1038/s41409-022-01587.
    PubMed     Abstract available


  96. NI F, Yin ETS, Zhou L, Zhao H, et al
    Outcomes of CD19 chimeric antigen receptor T cell followed by haploidentical hematopoietic stem-cell transplantation in relapsed/refractory B-cell acute lymphoblastic leukemia with IKZF1 deletion.
    Bone Marrow Transplant. 2022 Jan 24. pii: 10.1038/s41409-021-01554.
    PubMed    


  97. UTSUNOMIYA A, Tokunaga M, Nakano N, Fujiwara H, et al
    Long-term follow-up of patients with ATL after autologous stem cell transplantation.
    Bone Marrow Transplant. 2022 Jan 23. pii: 10.1038/s41409-021-01412.
    PubMed    


  98. KAWAJIRI A, Kawase T, Tanaka H, Fukuda T, et al
    Human leukocyte antigen (HLA) haplotype matching in unrelated single HLA allele mismatch bone marrow transplantation.
    Bone Marrow Transplant. 2022 Jan 21. pii: 10.1038/s41409-021-01552.
    PubMed     Abstract available


  99. MANNINA D, Badbaran A, Wolschke C, Klyuchnikov E, et al
    Digital-droplet PCR assays for IDH, DNMT3A and driver mutations to monitor after allogeneic stem cell transplantation minimal residual disease of myelofibrosis.
    Bone Marrow Transplant. 2022 Jan 19. pii: 10.1038/s41409-022-01566.
    PubMed    


  100. JEPPESEN H, Kielsen K, Siersma V, Lindegaard J, et al
    Ocular graft-versus-host disease and dry eye disease after paediatric haematopoietic stem cell transplantation - incidence and risk factors.
    Bone Marrow Transplant. 2022 Jan 18. pii: 10.1038/s41409-022-01564.
    PubMed     Abstract available


  101. HASHMI H, Shockley A, Davis JA
    'Save the day with a Stem Cell Rescue': Use of autologous hematopoietic stem cell boost for hematopoietic recovery after CAR T cell therapy.
    Bone Marrow Transplant. 2022 Jan 17. pii: 10.1038/s41409-022-01570.
    PubMed    


  102. SHAO DF, Li JH, Hu T, Zhang ZX, et al
    Clinical outcomes of individualized busulfan-dosing in hematopoietic stem cell transplantation in Chinese children undergoing with therapeutic drug monitoring.
    Bone Marrow Transplant. 2022 Jan 17. pii: 10.1038/s41409-021-01545.
    PubMed     Abstract available


  103. SHIMONI A
    Relapse of acute leukemia after a second allogeneic stem- cell transplantation; Is there any hope for cure?
    Bone Marrow Transplant. 2022 Jan 14. pii: 10.1038/s41409-021-01508.
    PubMed    


  104. SOERENSEN JF, Aggerholm A, Rosenberg CA, Bill M, et al
    Clonal evolution in patients developing therapy-related myeloid neoplasms following autologous stem cell transplantation.
    Bone Marrow Transplant. 2022 Jan 13. pii: 10.1038/s41409-022-01567.
    PubMed     Abstract available


  105. SHIMONI A, Labopin M, Angelucci E, Blaise D, et al
    The association of graft-versus-leukemia effect and graft-versus host disease in haploidentical transplantation with post-transplant cyclophosphamide for AML.
    Bone Marrow Transplant. 2022 Jan 13. pii: 10.1038/s41409-021-01493.
    PubMed     Abstract available


  106. TRUNK AD, Shewan SK, Lee CJ, Parker CJ, et al
    Chronic graft-versus-host disease exacerbation after SARS-CoV-2 vaccination.
    Bone Marrow Transplant. 2022 Jan 11. pii: 10.1038/s41409-021-01543.
    PubMed    


  107. VINCENT L, Gras L, Ceballos P, Finke J, et al
    Daratumumab after allogeneic hematopoietic cell transplantation for multiple myeloma is safe and synergies with pre-existing chronic graft versus host disease. A retrospective study from the CMWP EBMT.
    Bone Marrow Transplant. 2022 Jan 10. pii: 10.1038/s41409-021-01560.
    PubMed    


  108. LOSCHI M, Roux C, Sudaka I, Ferrero-Vacher C, et al
    Allogeneic stem cell transplantation as a curative therapeutic approach for VEXAS syndrome: a case report.
    Bone Marrow Transplant. 2022 Jan 9. pii: 10.1038/s41409-021-01544.
    PubMed     Abstract available


  109. EL HUSSEIN S, DiNardo CD, Takahashi K, Khoury JD, et al
    Acquired WT1 mutations contribute to relapse of NPM1-mutated acute myeloid leukemia following allogeneic hematopoietic stem cell transplant.
    Bone Marrow Transplant. 2022 Jan 7. pii: 10.1038/s41409-021-01538.
    PubMed     Abstract available


  110. ANDOLINA JR, Wang YC, Ji L, Freyer DR, et al
    Adolescent and young adult (AYA) versus pediatric patients with acute leukemia have a significantly increased risk of acute GVHD following unrelated donor (URD) stem cell transplantation (SCT): the Children's Oncology Group experience.
    Bone Marrow Transplant. 2022 Jan 6. pii: 10.1038/s41409-021-01558.
    PubMed     Abstract available


  111. STUTZ L, Halter JP, Heim D, Passweg JR, et al
    Low Incidence of hepatic sinusoidal obstruction syndrome/veno-occlusive disease in adults undergoing allogenic stem cell transplantation with prophylactic ursodiol and low-dose heparin.
    Bone Marrow Transplant. 2022 Jan 4. pii: 10.1038/s41409-021-01546.
    PubMed     Abstract available


  112. VELIER M, Daumas A, Simoncini S, Arcani R, et al
    Combining systemic and locally applied cellular therapies for the treatment of systemic sclerosis.
    Bone Marrow Transplant. 2022;57:17-22.
    PubMed     Abstract available


    December 2021
  113. BETHGE WA, Eyrich M, Mielke S, Meisel R, et al
    Results of a multicenter phase I/II trial of TCRalphabeta and CD19-depleted haploidentical hematopoietic stem cell transplantation for adult and pediatric patients.
    Bone Marrow Transplant. 2021 Dec 24. pii: 10.1038/s41409-021-01551.
    PubMed     Abstract available


    November 2021
  114. FURTADO VF, Brauneis D, Weinberg J, Elhassan N, et al
    Early serum free light chain response after high-dose melphalan and stem cell transplantation predicts hematologic response in AL amyloidosis.
    Bone Marrow Transplant. 2021 Nov 29. pii: 10.1038/s41409-021-01535.
    PubMed    


  115. LEAL CTS, Costa LJM, Pereira J, Duarte FB, et al
    Maximum-tolerated dose of lomustine used in combination with etoposide and cyclophosphamide in conditioning regimen for hematopoietic stem cell transplantation in lymphoma patients.
    Bone Marrow Transplant. 2021 Nov 29. pii: 10.1038/s41409-021-01531.
    PubMed    


  116. IMAHASHI N, Terakura S, Kondo E, Kato K, et al
    Impact of donor types on reduced-intensity conditioning allogeneic stem cell transplant for mature lymphoid malignancies.
    Bone Marrow Transplant. 2021 Nov 24. pii: 10.1038/s41409-021-01525.
    PubMed     Abstract available


  117. SHUMILOV E, Shakhanova I, Flach J, Schmidt N, et al
    Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantation.
    Bone Marrow Transplant. 2021 Nov 13. pii: 10.1038/s41409-021-01521.
    PubMed     Abstract available


  118. HOLIG K, Schmidt H, Hutter G, Kramer M, et al
    Correction to: Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial.
    Bone Marrow Transplant. 2021 Nov 12. pii: 10.1038/s41409-021-01523.
    PubMed    


  119. SCHETELIG J, Chevallier P, van Gelder M, Hoek J, et al
    Correction to: Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party.
    Bone Marrow Transplant. 2021 Nov 12. pii: 10.1038/s41409-021-01516.
    PubMed    


  120. OTTH M, Yammine S, Usemann J, Latzin P, et al
    Longitudinal lung function in childhood cancer survivors after hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Nov 8. pii: 10.1038/s41409-021-01509.
    PubMed     Abstract available


  121. SCHMID C, Labopin M, Schaap N, Veelken H, et al
    Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia.
    Bone Marrow Transplant. 2021 Nov 8. pii: 10.1038/s41409-021-01515.
    PubMed     Abstract available


  122. ALZAHRANI M, Damlaj M, Essa M, Alahmari B, et al
    HLA-identical related hematopoietic stem cell transplantation in severe sickle cell disease: age is not a barrier to successful outcome.
    Bone Marrow Transplant. 2021 Nov 6. pii: 10.1038/s41409-021-01513.
    PubMed    


  123. GARNICA M, Dalcolmo S, Gaio B, de Almeida AR, et al
    Pre-engraftment Cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation and its impact on engraftment.
    Bone Marrow Transplant. 2021 Nov 1. pii: 10.1038/s41409-021-01520.
    PubMed    


  124. KASIKIS S, Baez J, Gandhi I, Grupp S, et al
    Mesenchymal stromal cell therapy induces high responses and survival in children with steroid refractory GVHD and poor risk biomarkers.
    Bone Marrow Transplant. 2021;56:2869-2870.
    PubMed    


    October 2021
  125. MARTINO R, Garcia-Cadenas I, Esquirol A
    Daratumumab may be the most effective treatment for post-engraftment pure red cell aplasia due to persistent anti-donor isohemagglutinins after major ABO-mismatched allogeneic transplantation.
    Bone Marrow Transplant. 2021 Oct 28. pii: 10.1038/s41409-021-01507.
    PubMed    


  126. MIKULSKA M, Penack O, Wendel L, Knelange N, et al
    HEV infection in stem cell transplant recipients-retrospective study of EBMT Infectious Diseases Working Party.
    Bone Marrow Transplant. 2021 Oct 23. pii: 10.1038/s41409-021-01497.
    PubMed     Abstract available


  127. MARTINO M, Pitino A, Gori M, Viens P, et al
    Long-term survival in a fraction of patients with metastatic breast cancer who received consolidation therapy with high-dose chemotherapy and autologous stem cell transplant between 2000 and 2015: an EBMT registry-based study.
    Bone Marrow Transplant. 2021 Oct 23. pii: 10.1038/s41409-021-01503.
    PubMed    


  128. TIEN FM, Tsai CH, Huang SC, Liu JH, et al
    Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission.
    Bone Marrow Transplant. 2021 Oct 20. pii: 10.1038/s41409-021-01454.
    PubMed     Abstract available


  129. WANG X, Yu U, Yang C, Wang C, et al
    Cytomegalovirus (CMV)-specific cytotoxic T lymphocyte therapy resolve CMV diseases and refractory CMV infections in paediatric recipients of allogeneic haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Oct 20. pii: 10.1038/s41409-021-01499.
    PubMed    


  130. SMITH PJ, Lew M, Lowder Y, Romero K, et al
    Cognitive impairment in candidates for allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Oct 19. pii: 10.1038/s41409-021-01470.
    PubMed     Abstract available


  131. VO P, Onstad L, Flowers ME, Storb R, et al
    Cancers after HLA-matched related bone marrow transplantation for aplastic anemia.
    Bone Marrow Transplant. 2021 Oct 16. pii: 10.1038/s41409-021-01498.
    PubMed     Abstract available


  132. CARTER M, Taniguchi M, Yang D, Arslan S, et al
    Donor-specific HLA antibodies associate with chronic graft-versus-host disease in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide.
    Bone Marrow Transplant. 2021 Oct 11. pii: 10.1038/s41409-021-01494.
    PubMed    


  133. SALVINI M, Maggi F, Damonte C, Mortara L, et al
    Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation.
    Bone Marrow Transplant. 2021 Oct 11. pii: 10.1038/s41409-021-01487.
    PubMed    


  134. KOBAYASHI S, Kanda Y, Konuma T, Inamoto Y, et al
    Outcomes of third allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute leukemia after a second transplantation.
    Bone Marrow Transplant. 2021 Oct 8. pii: 10.1038/s41409-021-01485.
    PubMed     Abstract available


  135. SELLNER L, Schetelig J, Koster L, Choi G, et al
    Correction: Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey.
    Bone Marrow Transplant. 2021 Oct 7. pii: 10.1038/s41409-021-01490.
    PubMed    


  136. SAVOIA C, McKeough N, Hickey B, Cochrane T, et al
    Comparison of a therapeutic platelet transfusion strategy to a prophylactic platelet transfusion strategy in autologous stem cell transplant (ASCT), a single centre experience.
    Bone Marrow Transplant. 2021 Oct 6. pii: 10.1038/s41409-021-01482.
    PubMed    


  137. MILLARD T, Sammour F, Anthias C, Easdale S, et al
    Can pre-transplant 18F-choline positron emission tomography predict relapse following autologous stem cell transplantation in primary central nervous system lymphoma?
    Bone Marrow Transplant. 2021 Oct 5. pii: 10.1038/s41409-021-01484.
    PubMed    


  138. POIRE X, Graux C, Ory A, Herman J, et al
    Sequential administration of low dose 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation (SCT): a prospective s
    Bone Marrow Transplant. 2021 Oct 5. pii: 10.1038/s41409-021-01464.
    PubMed    


  139. PERRUCCIO K, Menconi M, Galaverna F, Pagliara D, et al
    Safety and efficacy of brincidofovir for Adenovirus infection in children receiving allogeneic stem cell transplantation: an AIEOP retrospective analyses.
    Bone Marrow Transplant. 2021 Oct 4. pii: 10.1038/s41409-021-01285.
    PubMed    


  140. NAKAMURA ZM, Heiling HM, Park EM, Deal AM, et al
    Impact of patient and clinical characteristics on cognitive changes after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Oct 2. pii: 10.1038/s41409-021-01481.
    PubMed    


    September 2021
  141. MAMEZ AC, Pradier A, Giannotti F, Petitpas A, et al
    Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2021 Sep 28. pii: 10.1038/s41409-021-01466.
    PubMed    


  142. PERIC Z, Peczynski C, Polge E, Kroger N, et al
    Influence of pretransplant inflammatory bowel disease on the outcome of allogeneic hematopoietic stem cell transplantation: a matched-pair analysis study from the Transplant Complications Working Party (TCWP) of the EBMT.
    Bone Marrow Transplant. 2021 Sep 24. pii: 10.1038/s41409-021-01458.
    PubMed    


  143. YOKOYAMA H, Hirayama M, Takahashi Y, Uchida N, et al
    Altered effect of killer immunoglobulin-like receptor-ligand mismatch by graft versus host disease prophylaxis in cord blood transplantation.
    Bone Marrow Transplant. 2021 Sep 24. pii: 10.1038/s41409-021-01469.
    PubMed     Abstract available


  144. RAMOS TL, Garcia-Guerrero E, Caballero-Velazquez T, Rodriguez-Gil A, et al
    Delayed administration of ixazomib modifies the immune response and prevents chronic graft-versus-host disease.
    Bone Marrow Transplant. 2021 Sep 23. pii: 10.1038/s41409-021-01452.
    PubMed     Abstract available


  145. ROCHA V, Arcuri LJ, Seber A, Colturato V, et al
    Impact of mother donor, peripheral blood stem cells and measurable residual disease on outcomes after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide in children with acute leukaemia.
    Bone Marrow Transplant. 2021 Sep 21. pii: 10.1038/s41409-021-01453.
    PubMed     Abstract available


  146. HOUIST AL, Bondeelle L, Salmona M, LeGoff J, et al
    Evaluation of prognostic scores for respiratory syncytial virus infection in a French multicentre cohort of allogeneic haematopoietic stem cell transplantation recipients.
    Bone Marrow Transplant. 2021 Sep 21. pii: 10.1038/s41409-021-01462.
    PubMed     Abstract available


  147. NIE D, Zhang J, Liu L, Li X, et al
    Targeted minor histocompatibility antigen typing to estimate graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Sep 16. pii: 10.1038/s41409-021-01459.
    PubMed     Abstract available


  148. SCORTECHINI I, Inglese E, Saraceni F, Poiani M, et al
    Central pontine myelinolysis after hematopoietic stem cell transplantation: survey in 169 consecutive transplanted patients and review of literature.
    Bone Marrow Transplant. 2021 Sep 16. pii: 10.1038/s41409-021-01361.
    PubMed    


  149. YAMAMOTO S, Kato M, Watanabe K, Ishimaru S, et al
    Prognostic value of the revised International Prognostic Scoring System five-group cytogenetic abnormality classification for the outcome prediction of hematopoietic stem cell transplantation in pediatric myelodysplastic syndrome.
    Bone Marrow Transplant. 2021 Sep 10. pii: 10.1038/s41409-021-01446.
    PubMed     Abstract available


  150. ABUELGASIM KA, Damlaj M, Bosaeed M, Altamimi S, et al
    Infectious complications in adult sickle cell anemia patients undergoing hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Sep 10. pii: 10.1038/s41409-021-01457.
    PubMed    


  151. PINCEZ T, Santiago R, Bittencourt H, Louis I, et al
    Intensive monitoring of minimal residual disease and chimerism after allogeneic hematopoietic stem cell transplantation for acute leukemia in children.
    Bone Marrow Transplant. 2021 Sep 2. pii: 10.1038/s41409-021-01408.
    PubMed     Abstract available


    August 2021
  152. DIAZ-DE-HEREDIA C, Bresters D, Faulkner L, Yesilipek A, et al
    Recommendations on hematopoietic stem cell transplantation for patients with Diamond-Blackfan anemia. On behalf of the Pediatric Diseases and Severe Aplastic Anemia Working Parties of the EBMT.
    Bone Marrow Transplant. 2021 Aug 31. pii: 10.1038/s41409-021-01449.
    PubMed     Abstract available


  153. AKDOGAN N, Ersoy-Evans S, Visal Okur F, Kuskonmaz B, et al
    Long-term skin findings in patients with Fanconi anemia after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Aug 27. pii: 10.1038/s41409-021-01441.
    PubMed    


  154. MALLADI R, Ahmed I, McIlroy G, Dignan FL, et al
    Azacitidine for the treatment of steroid-refractory chronic graft-versus-host disease: the results of the phase II AZTEC clinical trial.
    Bone Marrow Transplant. 2021 Aug 26. pii: 10.1038/s41409-021-01439.
    PubMed     Abstract available


  155. XU LP, Lu PH, Wu DP, Sun ZM, et al
    Hematopoietic stem cell transplantation activity in China 2019: a report from the Chinese Blood and Marrow Transplantation Registry Group.
    Bone Marrow Transplant. 2021 Aug 25. pii: 10.1038/s41409-021-01431.
    PubMed     Abstract available


  156. GOKLEMEZ S, Saligan LN, Pirsl F, Holtzman NG, et al
    Clinical characterization and cytokine profile of fatigue in hematologic malignancy patients with chronic graft-versus-host disease.
    Bone Marrow Transplant. 2021 Aug 25. pii: 10.1038/s41409-021-01419.
    PubMed     Abstract available


  157. SNARSKI E, Stringer J, Mikulska M, Gil L, et al
    Risk of infectious complications in adult patients after allogeneic hematopoietic stem cell transplantation depending on the site of central venous catheter insertion-multicenter prospective observational study, from the IDWP EBMT and Nurses Group of
    Bone Marrow Transplant. 2021 Aug 21. pii: 10.1038/s41409-021-01430.
    PubMed     Abstract available


  158. JANSSEN MJM, Bruns AHW, Verduyn Lunel FM, Raijmakers RAP, et al
    Predictive factors for vaccine failure to guide vaccination in allogeneic hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2021 Aug 20. pii: 10.1038/s41409-021-01437.
    PubMed     Abstract available


  159. MODEMANN F, Ayuk F, Wolschke C, Christopeit M, et al
    Correction: Ruxolitinib plus extracorporeal photopheresis (ECP) for steroid refractory acute graft-versus-host disease of lower GI-tract after allogeneic stem cell transplantation leads to increased regulatory T cell level.
    Bone Marrow Transplant. 2021 Aug 19. pii: 10.1038/s41409-021-01425.
    PubMed    


  160. WOLFF D, Herzberg PY, Herrmann A, Pavletic SZ, et al
    Correction: Post-transplant multimorbidity index and quality of life in patients with chronic graft-versus-host disease-results from a joint evaluation of a prospective German multicenter validation trial and a cohort from the National Institutes of H
    Bone Marrow Transplant. 2021 Aug 19. pii: 10.1038/s41409-021-01404.
    PubMed    


  161. WATERHOUSE M, Pennisi S, Pfeifer D, Deuter M, et al
    Correction: Colon and liver tissue damage detection using methylated SESN3 and PTK2B genes in circulating cell-free DNA in patients with acute graft-versus-host disease.
    Bone Marrow Transplant. 2021 Aug 19. pii: 10.1038/s41409-021-01405.
    PubMed    


  162. GRANELL M, Senin A, Barata A, Cibeira MT, et al
    Predictors of return to work after autologous stem cell transplantation in patients with multiple myeloma.
    Bone Marrow Transplant. 2021 Aug 17. pii: 10.1038/s41409-021-01429.
    PubMed     Abstract available


  163. JAYANI RV, Olin RL
    Physically "fit" for allogeneic stem cell transplant?
    Bone Marrow Transplant. 2021 Aug 16. pii: 10.1038/s41409-021-01436.
    PubMed    


  164. TAMAI H, Tajika K, Nakayama K, Arai A, et al
    Treatment of relapsed aggressive adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation with mogamulizumab followed by lenalidomide.
    Bone Marrow Transplant. 2021 Aug 12. pii: 10.1038/s41409-021-01432.
    PubMed    


  165. MISHRA A, Pidala J, Thapa R, Betts BC, et al
    Objective and subjective physical function in allogeneic hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2021 Aug 11. pii: 10.1038/s41409-021-01428.
    PubMed     Abstract available


  166. OHMOTO A, Fuji S
    Cardiac complications associated with hematopoietic stem-cell transplantation.
    Bone Marrow Transplant. 2021 Aug 11. pii: 10.1038/s41409-021-01427.
    PubMed     Abstract available


  167. WU Y, Zhao Y, Wang T, Xia J, et al
    Evaluation of diagnostic performance of metagenomic next-generation sequencing when applied in patients after allogeneic hematopoietic stem cell transplant.
    Bone Marrow Transplant. 2021 Aug 10. pii: 10.1038/s41409-021-01423.
    PubMed    


  168. THIEL U, Schober SJ, Ranft A, Gassmann H, et al
    Correction to: No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease.
    Bone Marrow Transplant. 2021 Aug 9. pii: 10.1038/s41409-021-01421.
    PubMed    


  169. CORNILLON J, Daguenet E, Tournilhac O, Blaise D, et al
    Allogeneic hematopoietic stem cell transplantation from unmanipulated haploidentical donor and unrelated cord blood for T-cell lymphoma: a retrospective study from the Societe Francophone de Greffe de Moelle et de Therapie Cellulaire.
    Bone Marrow Transplant. 2021 Aug 6. pii: 10.1038/s41409-021-01426.
    PubMed     Abstract available


    July 2021
  170. NIEDERWIESER C, Morozova E, Zubarovskaya L, Zabelina T, et al
    Risk factors for outcome after allogeneic stem cell transplantation in patients with advanced phase CML.
    Bone Marrow Transplant. 2021 Jul 30. pii: 10.1038/s41409-021-01410.
    PubMed     Abstract available


  171. LEW TE, Cliff ERS, Dickinson M, Tam CS, et al
    T-cell replete allogeneic stem cell transplant for mantle cell lymphoma achieves durable disease control, including against TP53-mutated disease.
    Bone Marrow Transplant. 2021 Jul 20. pii: 10.1038/s41409-021-01418.
    PubMed    


  172. KANG HM, Kim SK, Ryu IH, Lee JW, et al
    Clinical characteristics and viral load patterns in children with cytomegalovirus gastrointestinal disease after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Jul 17. pii: 10.1038/s41409-021-01394.
    PubMed     Abstract available


  173. ZUCENKA A, Vaitekenaite V, Maneikis K, Davainis L, et al
    Venetoclax-based salvage therapy followed by Venetoclax and DLI maintenance vs. FLAG-Ida for relapsed or refractory acute myeloid leukemia after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2021 Jul 17. pii: 10.1038/s41409-021-01416.
    PubMed     Abstract available


  174. ABO S, Ritchie D, Denehy L, Panek-Hudson Y, et al
    Feasibility of early-commencing group-based exercise in allogeneic bone marrow transplantation: the BOOST study.
    Bone Marrow Transplant. 2021 Jul 16. pii: 10.1038/s41409-021-01411.
    PubMed     Abstract available


  175. JENTZSCH M, Grimm J, Bill M, Kupper J, et al
    Measurable residual disease of canonical versus non-canonical DNMT3A, TET2, or ASXL1 mutations in AML at stem cell transplantation.
    Bone Marrow Transplant. 2021 Jul 15. pii: 10.1038/s41409-021-01407.
    PubMed    


  176. KONDO G, Ishimaru F, Konuma T, Takahashi S, et al
    Cord blood index predicts engraftment and early non-relapse mortality in adult patients with single-unit cord blood transplantation.
    Bone Marrow Transplant. 2021 Jul 15. pii: 10.1038/s41409-021-01406.
    PubMed     Abstract available


  177. CUVELIER S, Blaise D, Boher JM, Villaron-Goetgheluck C, et al
    A study of elite sport-inspired coaching for patients after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Jul 14. pii: 10.1038/s41409-021-01401.
    PubMed     Abstract available


  178. LUFT T, Dreger P, Radujkovic A
    Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2021 Jul 12. pii: 10.1038/s41409-021-01390.
    PubMed     Abstract available


  179. ALARCON TOMAS A, Whiting K, Maloy M, Ruiz JD, et al
    The post-transplant scoring system (PTSS) is associated with outcomes in patients with MDS after CD34+selected allogeneic stem cell transplant.
    Bone Marrow Transplant. 2021 Jul 12. pii: 10.1038/s41409-021-01392.
    PubMed     Abstract available


  180. BORTNICK R, Wlodarski M, de Haas V, De Moerloose B, et al
    Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome.
    Bone Marrow Transplant. 2021 Jul 9. pii: 10.1038/s41409-021-01374.
    PubMed     Abstract available


  181. TANG FF, Zhao XY, Huo MR, Chang YJ, et al
    Comparison of the clinical outcomes between NIMA-mismatched and NIPA-mismatched haploidentical hematopoietic stem cell transplantation for patients with hematological malignancies.
    Bone Marrow Transplant. 2021 Jul 8. pii: 10.1038/s41409-021-01382.
    PubMed     Abstract available


  182. COSTA TCM, Chiari-Correia R, Salmon CEG, Darrigo-Junior LG, et al
    Hematopoietic stem cell transplantation reverses white matter injury measured by diffusion-tensor imaging (DTI) in sickle cell disease patients.
    Bone Marrow Transplant. 2021 Jul 7. pii: 10.1038/s41409-021-01365.
    PubMed     Abstract available


  183. LANKESTER AC, Albert MH, Booth C, Gennery AR, et al
    EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity.
    Bone Marrow Transplant. 2021 Jul 5. pii: 10.1038/s41409-021-01378.
    PubMed    


  184. BAA AK, Chellapuram SK, Sharma A, Malik PS, et al
    Poems syndrome: consolidation with autologous stem cell transplantation.
    Bone Marrow Transplant. 2021 Jul 5. pii: 10.1038/s41409-021-01395.
    PubMed    


  185. PRYCE A, Mir F, Ushiro-Lumb I, Drypen R, et al
    SARS-CoV-2 respiratory screening of asymptomatic stem cell donors on day of collection; to test or not to test. UK Aligned Stem Cell Donor Registry.
    Bone Marrow Transplant. 2021 Jul 5. pii: 10.1038/s41409-021-01379.
    PubMed    


  186. LIU L, Miao M, Chen X, Zhang Y, et al
    Outcomes of severe aplastic anemia patients with infection proceeding with allogeneic hematopoietic stem cell transplantation, versus patients without infection.
    Bone Marrow Transplant. 2021 Jul 3. pii: 10.1038/s41409-021-01398.
    PubMed    


  187. WOLFF D, Fatobene G, Rocha V, Kroger N, et al
    Steroid-refractory chronic graft-versus-host disease: treatment options and patient management.
    Bone Marrow Transplant. 2021 Jul 3. pii: 10.1038/s41409-021-01389.
    PubMed     Abstract available


  188. ANSARI M, Petrykey K, Rezgui MA, Del Vecchio V, et al
    Genetic susceptibility to acute graft versus host disease in pediatric patients undergoing HSCT.
    Bone Marrow Transplant. 2021 Jul 2. pii: 10.1038/s41409-021-01386.
    PubMed     Abstract available


  189. LUCIA A, Fiuza-Luces C
    Physical fitness and childhood hematopoietic stem cell transplantation: a call to action.
    Bone Marrow Transplant. 2021 Jul 1. pii: 10.1038/s41409-021-01397.
    PubMed    


    June 2021
  190. LUPO-STANGHELLINI MT, Xue E, Mastaglio S, Oltolini C, et al
    COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome.
    Bone Marrow Transplant. 2021 Jun 30. pii: 10.1038/s41409-021-01278.
    PubMed    


  191. LEMIEUX C, Muffly LS, Iberri DJ, Craig JK, et al
    Outcomes after delayed and second autologous stem cell transplant in patients with relapsed multiple myeloma.
    Bone Marrow Transplant. 2021 Jun 23. pii: 10.1038/s41409-021-01371.
    PubMed     Abstract available


  192. GILFANOVA R, Callegari A, Childs A, Yang G, et al
    A bioinspired and chemically defined alternative to dimethyl sulfoxide for the cryopreservation of human hematopoietic stem cells.
    Bone Marrow Transplant. 2021 Jun 21. pii: 10.1038/s41409-021-01368.
    PubMed     Abstract available


  193. FRIDH MK, Simonsen C, Schmidt-Andersen P, Nissen AA, et al
    Cardiorespiratory fitness and physical performance after childhood hematopoietic stem cell transplantation: a systematic review and meta-analysis.
    Bone Marrow Transplant. 2021 Jun 21. pii: 10.1038/s41409-021-01370.
    PubMed     Abstract available


  194. BERGERON A
    Tuberculosis in allogeneic haematopoietic stem cell transplantation: so many unresolved questions!
    Bone Marrow Transplant. 2021 Jun 18. pii: 10.1038/s41409-021-01381.
    PubMed    


  195. FERNANDEZ-SOJO J, Azqueta C, Valdivia E, Martorell L, et al
    Cryopreservation of unrelated donor hematopoietic stem cells: the right answer for transplantations during the COVID-19 pandemic?
    Bone Marrow Transplant. 2021 Jun 14. pii: 10.1038/s41409-021-01367.
    PubMed     Abstract available


  196. BONIFAZI F, Defrancesco I, Olivieri J, Barbato F, et al
    Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomas.
    Bone Marrow Transplant. 2021 Jun 9. pii: 10.1038/s41409-021-01359.
    PubMed    


  197. FLOISAND Y, Schroeder MA, Chevallier P, Selleslag D, et al
    A phase 2a randomized clinical trial of intravenous vedolizumab for the treatment of steroid-refractory intestinal acute graft-versus-host disease.
    Bone Marrow Transplant. 2021 Jun 9. pii: 10.1038/s41409-021-01356.
    PubMed     Abstract available


  198. KAWASHIMA N, Nishikawa E, Tsuchisaka A, Hashimoto T, et al
    Autoantibodies against the plakin family proteins as a novel marker for chronic graft-versus-host disease of the lung.
    Bone Marrow Transplant. 2021 Jun 9. pii: 10.1038/s41409-021-01335.
    PubMed    


    May 2021
  199. ESQUIROL A, Pascual MJ, Kwon M, Perez A, et al
    Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide.
    Bone Marrow Transplant. 2021 May 31. pii: 10.1038/s41409-021-01328.
    PubMed     Abstract available


  200. WAIDHAUSER J, Labopin M, Esteve J, Kroger N, et al
    Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT.
    Bone Marrow Transplant. 2021 May 31. pii: 10.1038/s41409-021-01322.
    PubMed     Abstract available


  201. KUMARI R, Palaniyandi S, Hildebrandt GC
    The microbiome-the revealing of a long time unbeknownst factor for outcome in murine models of graft-versus-host disease.
    Bone Marrow Transplant. 2021 May 29. pii: 10.1038/s41409-021-01325.
    PubMed    


  202. SUN X, Yang J, Cai Y, Wan L, et al
    Low-dose antithymocyte globulin plus low-dose posttransplant cyclophosphamide combined with cyclosporine and mycophenolate mofetil for prevention of graft-versus-host disease after HLA-matched unrelated donor peripheral blood stem cell transplantation
    Bone Marrow Transplant. 2021 May 25. pii: 10.1038/s41409-021-01358.
    PubMed     Abstract available


  203. GRECO R, Alexander T, Burman J, Del Papa N, et al
    Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations.
    Bone Marrow Transplant. 2021 May 24. pii: 10.1038/s41409-021-01326.
    PubMed     Abstract available


  204. LACY M, Fong M, Bolton C, Maranzano M, et al
    Cognitive functioning of older adults prior to hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 May 24. pii: 10.1038/s41409-021-01331.
    PubMed     Abstract available


  205. KUZICH JA, Kankanige Y, Guinto J, Ryland G, et al
    T cell receptor beta locus sequencing early post-allogeneic stem cell transplant identifies patients at risk of initial and recurrent cytomegalovirus infection.
    Bone Marrow Transplant. 2021 May 24. pii: 10.1038/s41409-021-01354.
    PubMed     Abstract available


  206. MIKULSKA M, Tridello G, Hoek J, Gil L, et al
    Legionellosis after hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 May 22. pii: 10.1038/s41409-021-01333.
    PubMed     Abstract available


  207. BEAUVERD Y, Morin S, Stephan C, De Ramon Ortiz C, et al
    The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients transplanted with in vitro partial T-cell depleted graft.
    Bone Marrow Transplant. 2021 May 18. pii: 10.1038/s41409-021-01334.
    PubMed    


  208. SHIMOMURA Y, Hara M, Konuma T, Itonaga H, et al
    Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome in adolescent and young adult patients.
    Bone Marrow Transplant. 2021 May 15. pii: 10.1038/s41409-021-01324.
    PubMed     Abstract available


  209. SEO S, Usui Y, Matsuo K, Atsuta Y, et al
    Impact of the combination of donor age and HLA disparity on the outcomes of unrelated bone marrow transplantation.
    Bone Marrow Transplant. 2021 May 14. pii: 10.1038/s41409-021-01289.
    PubMed     Abstract available


  210. VIJENTHIRA A, Kuruvilla J, Prica A
    Cost-effectiveness analysis of allogeneic versus autologous stem cell transplant versus chemo-immunotherapy for early relapse of follicular lymphoma within 2 years of initial therapy.
    Bone Marrow Transplant. 2021 May 13. pii: 10.1038/s41409-021-01327.
    PubMed     Abstract available


  211. XU L, Feng J, Xu X, Li X, et al
    IL-17-producing gammadeltaT cells ameliorate intestinal acute graft-versus-host disease by recruitment of Gr-1(+)CD11b(+) myeloid-derived suppressor cells.
    Bone Marrow Transplant. 2021 May 13. pii: 10.1038/s41409-021-01299.
    PubMed     Abstract available


  212. MURATA M, Terakura S, Wake A, Miyao K, et al
    Off-the-shelf bone marrow-derived mesenchymal stem cell treatment for acute graft-versus-host disease: real-world evidence.
    Bone Marrow Transplant. 2021 May 11. pii: 10.1038/s41409-021-01304.
    PubMed     Abstract available


  213. PIETRASZKIEWICZ AA, Payne D, Abraham M, Garced A, et al
    Correction: Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort study.
    Bone Marrow Transplant. 2021 May 10. pii: 10.1038/s41409-021-01315.
    PubMed    


  214. ALBERT MH, Sirin M, Hoenig M, Hauck F, et al
    Salvage HLA-haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide for graft failure in non-malignant disorders.
    Bone Marrow Transplant. 2021 May 9. pii: 10.1038/s41409-021-01323.
    PubMed     Abstract available


  215. DE OLIVEIRA RODRIGUES M, de Almeida Testa LH, Dos Santos ACF, Zanetti LP, et al
    Latent and active tuberculosis infection in allogeneic hematopoietic stem cell transplant recipients: a prospective cohort study.
    Bone Marrow Transplant. 2021 May 8. pii: 10.1038/s41409-021-01329.
    PubMed     Abstract available


  216. SHIRATORI S, Sugita J, Fuji S, Aoki J, et al
    Low-dose antithymocyte globulin inhibits chronic graft-versus-host disease in peripheral blood stem cell transplantation from unrelated donors.
    Bone Marrow Transplant. 2021 May 7. pii: 10.1038/s41409-021-01314.
    PubMed     Abstract available


  217. DERENZINI E, Tabanelli V, Sammassimo S, Mazzara S, et al
    Pre-existing immune checkpoints activation predicts relapse after allogeneic stem cell transplantation in lymphoma.
    Bone Marrow Transplant. 2021 May 7. pii: 10.1038/s41409-021-01320.
    PubMed    


  218. FRIEDMAN D, Dozor AJ, Milner J, D'Souza M, et al
    Stable to improved cardiac and pulmonary function in children with high-risk sickle cell disease following haploidentical stem cell transplantation.
    Bone Marrow Transplant. 2021 May 6. pii: 10.1038/s41409-021-01298.
    PubMed     Abstract available


  219. KALOYANNIDIS P, Ayyad A, Bahaliwah Z, Blowi B, et al
    Ibrutinib for steroid refractory chronic graft-versus-host disease: therapeutic efficiency can be limited by increased risk of fungal infection.
    Bone Marrow Transplant. 2021 May 4. pii: 10.1038/s41409-021-01318.
    PubMed    


  220. DE LA PUERTA R, Montoro J, Aznar C, Lorenzo I, et al
    Common seasonal respiratory virus infections in allogeneic stem cell transplant recipients during the SARS-COV-2 pandemic.
    Bone Marrow Transplant. 2021 May 4. pii: 10.1038/s41409-021-01319.
    PubMed     Abstract available


  221. OOSTENBRINK LVE, Pool ES, Jol-van der Zijde CM, Jansen-Hoogendijk AM, et al
    Successful mismatched hematopoietic stem cell transplantation for pediatric hemoglobinopathy by using ATG and post-transplant cyclophosphamide.
    Bone Marrow Transplant. 2021 May 3. pii: 10.1038/s41409-021-01302.
    PubMed     Abstract available


    April 2021
  222. TOYODA K, Yasunaga JI, Choi I, Suehiro Y, et al
    The HTLV-1 proviral status is a potential prognostic biomarker for adult T-cell leukemia-lymphoma treated with allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2021 Apr 29. pii: 10.1038/s41409-021-01311.
    PubMed    


  223. HARADA K, Kimura SI, Fuji S, Najima Y, et al
    Prognostic factors in salvage transplantation for graft failure following allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Apr 29. pii: 10.1038/s41409-021-01310.
    PubMed     Abstract available


  224. SAITO Y, Urashima M, Takahashi Y, Ogawa A, et al
    Effect of high-dose chemotherapy plus stem cell rescue on the survival of patients with neuroblastoma modified by MYCN gene gain/amplification and remission status: a nationwide registration study in Japan.
    Bone Marrow Transplant. 2021 Apr 28. pii: 10.1038/s41409-021-01303.
    PubMed     Abstract available


  225. BURT RK, Muraro PA, Farge D, Oliveira MC, et al
    New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosis.
    Bone Marrow Transplant. 2021 Apr 28. pii: 10.1038/s41409-021-01277.
    PubMed     Abstract available


  226. RAGON BK
    FLT3-ITDos and FLT3-ITDon'ts: navigating maintenance therapy in FLT3-ITD-positive acute myeloid leukemia following stem cell transplantation.
    Bone Marrow Transplant. 2021 Apr 28. pii: 10.1038/s41409-021-01269.
    PubMed    


  227. AMONOO HL, El-Jawahri A, Celano CM, Brown LA, et al
    A positive psychology intervention to promote health outcomes in hematopoietic stem cell transplantation: the PATH proof-of-concept trial.
    Bone Marrow Transplant. 2021 Apr 20. pii: 10.1038/s41409-021-01296.
    PubMed     Abstract available


  228. INOUE Y, Okinaka K, Fuji S, Inamoto Y, et al
    Severe acute graft-versus-host disease increases the incidence of blood stream infection and mortality after allogeneic hematopoietic cell transplantation: Japanese transplant registry study.
    Bone Marrow Transplant. 2021 Apr 19. pii: 10.1038/s41409-021-01291.
    PubMed     Abstract available


  229. FIALA MA, King J, Feinberg D, Goldsmith SR, et al
    Autologous stem cell transplant for patients with multiple myeloma between ages 75 and 78.
    Bone Marrow Transplant. 2021 Apr 19. pii: 10.1038/s41409-021-01295.
    PubMed    


  230. RUSSO D, Polverelli N, Malagola M, Farina M, et al
    Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey).
    Bone Marrow Transplant. 2021 Apr 19. pii: 10.1038/s41409-021-01287.
    PubMed     Abstract available


  231. EYRE TA, Caillard S, Finel H, Boumendil A, et al
    Autologous stem cell transplantation for post-transplant lymphoproliferative disorders after solid organ transplantation: a retrospective analysis from the Lymphoma Working Party of the EBMT.
    Bone Marrow Transplant. 2021 Apr 16. pii: 10.1038/s41409-021-01270.
    PubMed     Abstract available


  232. RAMDIAL JL, Mehta RS, Saliba RM, Alousi AM, et al
    Acute graft-versus-host disease is the foremost cause of late nonrelapse mortality.
    Bone Marrow Transplant. 2021 Apr 12. pii: 10.1038/s41409-021-01274.
    PubMed     Abstract available


  233. WU J, Fu HX, He Y, Mo XD, et al
    Risk factors and outcomes of diffuse alveolar haemorrhage after allogeneic haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Apr 12. pii: 10.1038/s41409-021-01293.
    PubMed     Abstract available


  234. EGLSEER D, Bauer S, Huber-Krassnitzer B, Greinix H, et al
    Malnutrition risk prior to hematopoietic stem cell transplantation predicts mortality in adults.
    Bone Marrow Transplant. 2021 Apr 12. pii: 10.1038/s41409-021-01292.
    PubMed     Abstract available


  235. NELSON AM, Johnson PC, Kavanaugh AR, Jackson VA, et al
    Palliative care for patients undergoing stem cell transplant: intervention components and supportive care measures.
    Bone Marrow Transplant. 2021 Apr 6. pii: 10.1038/s41409-021-01281.
    PubMed     Abstract available


  236. BADAR T, Szabo A, Litzow M, Burkart M, et al
    Multi-institutional study evaluating clinical outcome with allogeneic hematopoietic stem cell transplantation after blinatumomab in patients with B-cell acute lymphoblastic leukemia: real-world data.
    Bone Marrow Transplant. 2021 Apr 6. pii: 10.1038/s41409-021-01279.
    PubMed     Abstract available


  237. LIU W, Fan Z, Zhang Y, Huang F, et al
    Metagenomic next-generation sequencing for identifying pathogens in central nervous system complications after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Apr 6. pii: 10.1038/s41409-021-01243.
    PubMed     Abstract available


  238. HAGHIRI S, Fayech C, Mansouri I, Dufour C, et al
    Long-term follow-up of high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell transplantation rescue.
    Bone Marrow Transplant. 2021 Apr 6. pii: 10.1038/s41409-021-01258.
    PubMed     Abstract available


  239. STATHOPOULOS P, Leger K, Foege M, Lutterotti A, et al
    Autologous hematopoietic stem cell transplantation in multiple sclerosis: a global approval and availability review.
    Bone Marrow Transplant. 2021 Apr 6. pii: 10.1038/s41409-021-01276.
    PubMed    


    March 2021
  240. DAHER-REYES G, Kim T, Novitzky-Basso I, Kim KH, et al
    Prognostic impact of the adverse molecular-genetic profile on long-term outcomes following allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.
    Bone Marrow Transplant. 2021 Mar 25. pii: 10.1038/s41409-021-01255.
    PubMed     Abstract available


  241. BENTO L, Gutierrez A, Novelli S, Montoro J, et al
    Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study.
    Bone Marrow Transplant. 2021 Mar 25. pii: 10.1038/s41409-021-01264.
    PubMed     Abstract available


  242. LAZZARO C, Castagna L, Lanza F, Laszlo D, et al
    Chemotherapy-based versus chemotherapy-free stem cell mobilization (+/- plerixafor) in multiple myeloma patients: an Italian cost-effectiveness analysis.
    Bone Marrow Transplant. 2021 Mar 22. pii: 10.1038/s41409-021-01251.
    PubMed     Abstract available


  243. IMOTO H, Yoshioka S, Hiramoto N, Morita-Fujita M, et al
    Haploidentical peripheral blood stem cell transplantation with posttransplant cyclophosphamide for systemic Epstein-Barr virus-positive T-cell lymphoma of childhood.
    Bone Marrow Transplant. 2021 Mar 10. pii: 10.1038/s41409-021-01263.
    PubMed    


  244. PIETRASZKIEWICZ AA, Payne D, Abraham M, Garced A, et al
    Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort study.
    Bone Marrow Transplant. 2021 Mar 8. pii: 10.1038/s41409-021-01254.
    PubMed     Abstract available


  245. KONISHI T, Kusakabe S, Hino A, Inamoto K, et al
    Low diversity of gut microbiota in the early phase of post-bone marrow transplantation increases the risk of chronic graft-versus-host disease.
    Bone Marrow Transplant. 2021 Mar 8. pii: 10.1038/s41409-021-01249.
    PubMed    


  246. KAPOOR J, Khushoo V, Garg A, Naim F, et al
    An "impossible" harvest-GCSF-induced immune thrombocytopenia in an autologous stem cell transplant recipient with multiple myeloma.
    Bone Marrow Transplant. 2021 Mar 8. pii: 10.1038/s41409-021-01256.
    PubMed    


  247. SHAH RM
    Contemporary haploidentical stem cell transplant strategies in children with hematological malignancies.
    Bone Marrow Transplant. 2021 Mar 5. pii: 10.1038/s41409-021-01246.
    PubMed     Abstract available


  248. RUGGERI A, Labopin M, Angelucci E, Blaise D, et al
    Prognostic factors for neutrophil engraftment after haploidentical cell transplantation with PT-Cy in patients with acute myeloid leukemia in complete remission, on behalf of the ALWP-EBMT.
    Bone Marrow Transplant. 2021 Mar 5. pii: 10.1038/s41409-021-01248.
    PubMed     Abstract available


  249. RITACCO C, Ehx G, Gregoire C, Daulne C, et al
    High proportion of terminally differentiated regulatory T cells after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Mar 4. pii: 10.1038/s41409-021-01221.
    PubMed     Abstract available


  250. REUSING SB, Manser AR, Groeneveld-Krentz S, Rebmann V, et al
    HLA-E expression constitutes a novel determinant for ALL disease monitoring following hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Mar 3. pii: 10.1038/s41409-021-01231.
    PubMed    


  251. ELMARIAH H, Naqvi SMH, Kim J, Nishihori T, et al
    Impact of infused CD34+ stem cell dosing for allogeneic peripheral blood stem cell transplantation with post-transplant cyclophosphamide.
    Bone Marrow Transplant. 2021 Mar 3. pii: 10.1038/s41409-021-01219.
    PubMed     Abstract available


  252. SHIMOMURA Y, Hara M, Yamamoto H, Uchida N, et al
    Adding melphalan to fludarabine and a myeloablative dose of busulfan improved survival after allogeneic hematopoietic stem cell transplantation in a propensity score-matched cohort of hematological malignancies.
    Bone Marrow Transplant. 2021 Mar 3. pii: 10.1038/s41409-021-01217.
    PubMed     Abstract available


  253. PULIAFITO B, Zhao Y, Afshar S, Galitzeck Z, et al
    Comparison of post-transplant vaccination among allogeneic and autologous hematopoietic stem cell transplant patients: a single center quality analysis.
    Bone Marrow Transplant. 2021 Mar 1. pii: 10.1038/s41409-021-01240.
    PubMed    


    February 2021
  254. TANG X, Valdez BC, Ma Y, Zhang Q, et al
    Low-dose decitabine as part of a modified Bu-Cy conditioning regimen improves survival in AML patients with active disease undergoing allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Feb 26. pii: 10.1038/s41409-021-01238.
    PubMed     Abstract available


  255. MISKIEWICZ-BUJNA J, Miskiewicz-Migon I, Panasiuk A, Kubica-Cielinska A, et al
    Severe and fatal toxicity after hematopoietic stem cell transplantation in GNE defect-associated thrombocytopenia.
    Bone Marrow Transplant. 2021 Feb 26. pii: 10.1038/s41409-021-01235.
    PubMed    


  256. LAI X, Liu L, Zhang Z, Shi L, et al
    Hepatic veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation for thalassemia major: incidence, management, and outcome.
    Bone Marrow Transplant. 2021 Feb 19. pii: 10.1038/s41409-021-01233.
    PubMed     Abstract available


  257. CHRISTOPEIT M, Reichard M, Niederwieser C, Massoud R, et al
    Allogeneic stem cell transplantation in acute leukemia patients after COVID-19 infection.
    Bone Marrow Transplant. 2021 Feb 9. pii: 10.1038/s41409-021-01225.
    PubMed    


  258. SHEIKH MA, Im A, Ballen K, Hashmi SK, et al
    Association of graft-versus-host-disease with neurologic complications: clinical paradigm and future directions.
    Bone Marrow Transplant. 2021 Feb 9. pii: 10.1038/s41409-021-01216.
    PubMed    


  259. PAUTAS C, Raffoux E, Lambert J, Legrand O, et al
    Outcomes following hematopoietic stem cell transplantation in patients treated with standard chemotherapy with or without gemtuzumab ozogamicin for acute myeloid leukemia.
    Bone Marrow Transplant. 2021 Feb 9. pii: 10.1038/s41409-020-01207.
    PubMed     Abstract available


  260. RUBEN CL, Pirsl F, Steinberg SM, Holtzman NG, et al
    Predictors of hematologic malignancy relapse in patients with advanced chronic graft-versus-host disease.
    Bone Marrow Transplant. 2021 Feb 1. pii: 10.1038/s41409-021-01211.
    PubMed     Abstract available


  261. PRINCE HM, Abeyakoon C
    Allogeneic haematopoietic stem cell transplantation for advanced stage mycosis fungoides and Sezary syndrome: never-late, never-never?
    Bone Marrow Transplant. 2021 Feb 1. pii: 10.1038/s41409-020-01150.
    PubMed    


    January 2021
  262. DAI H, Penack O, Radujkovic A, Schult D, et al
    Early bilirubinemia after allogeneic stem cell transplantation-an endothelial complication.
    Bone Marrow Transplant. 2021 Jan 30. pii: 10.1038/s41409-020-01186.
    PubMed     Abstract available


  263. AHMED N, Li L, Rojas P, Covut F, et al
    Significant costs and low utilization of stored peripheral blood stem cells for salvage autologous transplant in multiple myeloma patients including those meeting mSMART criteria.
    Bone Marrow Transplant. 2021 Jan 29. pii: 10.1038/s41409-021-01223.
    PubMed    


  264. SAKURAI M, Mori T, Kato K, Kanaya M, et al
    Outcome of allogeneic hematopoietic stem cell transplantation for follicular lymphoma relapsing after autologous transplantation: analysis of the Japan Society for Hematopoietic Cell Transplantation.
    Bone Marrow Transplant. 2021 Jan 29. pii: 10.1038/s41409-020-01192.
    PubMed    


  265. CESARO S, Tridello G, Knelange NS, Blijlevens N, et al
    Impact of early candidemia on the long-term outcome of allogeneic hematopoietic stem cell transplant in non-leukemic patients: an outcome analysis on behalf of IDWP-EBMT.
    Bone Marrow Transplant. 2021 Jan 29. pii: 10.1038/s41409-021-01212.
    PubMed     Abstract available


  266. THIEL U, Schober SJ, Ranft A, Gassmann H, et al
    No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease.
    Bone Marrow Transplant. 2021 Jan 29. pii: 10.1038/s41409-020-01200.
    PubMed     Abstract available


  267. LOPEZ R, Plat G, Bertrand Y, Ducassou S, et al
    Testosterone deficiency in men surviving childhood acute leukemia after treatment with hematopoietic stem cell transplantation or testicular radiation: an L.E.A. study.
    Bone Marrow Transplant. 2021 Jan 16. pii: 10.1038/s41409-020-01180.
    PubMed     Abstract available


  268. VAN LEEUWEN SJM, Proctor GB, Laheij AMGA, Potting CMJ, et al
    Significant salivary changes in relation to oral mucositis following autologous hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Jan 8. pii: 10.1038/s41409-020-01185.
    PubMed     Abstract available


  269. WEI N, Wang Y, Wang J, Wu L, et al
    Characteristics of Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active Epstein-Barr virus disease: favorable responses to rituximab.
    Bone Marrow Transplant. 2021 Jan 8. pii: 10.1038/s41409-020-01193.
    PubMed    


  270. DOMINGO-DOMENECH E, Duarte RF, Boumedil A, Onida F, et al
    Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sezary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.
    Bone Marrow Transplant. 2021 Jan 8. pii: 10.1038/s41409-020-01197.
    PubMed     Abstract available


  271. WALLACE G, Khandelwal P, Myers KC, Perentesis EMR, et al
    Prospective pilot trial of calcipotriene as a novel topical treatment for acute skin graft versus host disease.
    Bone Marrow Transplant. 2021 Jan 8. pii: 10.1038/s41409-020-01189.
    PubMed     Abstract available


  272. OKOEV G, Weisdorf DJ, Wagner JE, Blazar BR, et al
    Outcomes of chronic graft-versus-host disease following matched sibling donor versus umbilical cord blood transplant.
    Bone Marrow Transplant. 2021 Jan 8. pii: 10.1038/s41409-020-01195.
    PubMed     Abstract available


  273. SUN X, Su Y, Liu X, Zhang Y, et al
    Overt gastrointestinal bleeding following haploidentical haematopoietic stem cell transplantation: incidence, outcomes and predictive models.
    Bone Marrow Transplant. 2021 Jan 7. pii: 10.1038/s41409-020-01187.
    PubMed     Abstract available


    December 2020
  274. GIAMMARCO S, Raiola AM, Di Grazia C, Bregante S, et al
    Second haploidentical stem cell transplantation for primary graft failure.
    Bone Marrow Transplant. 2020 Dec 16. pii: 10.1038/s41409-020-01183.
    PubMed     Abstract available


  275. XU ZL, Huang XJ
    Haploidentical stem cell transplantation for aplastic anemia: the current advances and future challenges.
    Bone Marrow Transplant. 2020 Dec 15. pii: 10.1038/s41409-020-01169.
    PubMed     Abstract available


  276. SANZ J, Labopin M, Sanz MA, Aljurf M, et al
    Hematopoietic stem cell transplantation for adults with relapsed acute promyelocytic leukemia in second complete remission.
    Bone Marrow Transplant. 2020 Dec 15. pii: 10.1038/s41409-020-01162.
    PubMed     Abstract available


  277. SOLANO C, Vazquez L, Gimenez E, de la Camara R, et al
    Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment.
    Bone Marrow Transplant. 2020 Dec 15. pii: 10.1038/s41409-020-01157.
    PubMed     Abstract available


  278. MORI T, Kikuchi T, Koh M, Koda Y, et al
    Cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation under cytomegalovirus antigenemia-guided active screening.
    Bone Marrow Transplant. 2020 Dec 12. pii: 10.1038/s41409-020-01176.
    PubMed     Abstract available


  279. MONTORO J, Chorao P, Bento L, Cabrero M, et al
    Risk factors and outcomes of follicular lymphoma after allogeneic hematopoietic stem cell transplantation using HLA-matched sibling, unrelated, and haploidentical-related donors.
    Bone Marrow Transplant. 2020 Dec 12. pii: 10.1038/s41409-020-01161.
    PubMed    


  280. MURILLO-SANJUAN L, Gonzalez-Vicent M, Argiles Aparicio B, Badell Serra I, et al
    Survival and toxicity outcomes of hematopoietic stem cell transplantation for pediatric patients with Fanconi anemia: a unified multicentric national study from the Spanish Working Group for Bone Marrow Transplantation in Children.
    Bone Marrow Transplant. 2020 Dec 10. pii: 10.1038/s41409-020-01172.
    PubMed     Abstract available


  281. HIRSCHBUHL K, Labopin M, Houhou M, Gabellier L, et al
    Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working Party.
    Bone Marrow Transplant. 2020 Dec 9. pii: 10.1038/s41409-020-01173.
    PubMed     Abstract available


  282. MAZIARZ RT, Levis M, Patnaik MM, Scott BL, et al
    Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia.
    Bone Marrow Transplant. 2020 Dec 7. pii: 10.1038/s41409-020-01153.
    PubMed     Abstract available


  283. BAKER LX, Chen F, Ssempijja Y, Byrne M, et al
    Longitudinal tracking of skin dynamic stiffness to quantify evolution of sclerosis in chronic graft-versus-host disease.
    Bone Marrow Transplant. 2020 Dec 5. pii: 10.1038/s41409-020-01158.
    PubMed    


  284. SONG GY, Yoon DH, Suh C, Moon JH, et al
    Open-label, single arm, multicenter phase II study of VIDL induction chemotherapy followed by upfront autologous stem cell transplantation in patients with advanced stage extranodal NK/T-cell lymphoma.
    Bone Marrow Transplant. 2020 Dec 4. pii: 10.1038/s41409-020-01160.
    PubMed     Abstract available


  285. BAI B, Wang XX, Gao Y, Li PF, et al
    Prior anti-PD-1 therapy as a risk factor for life-threatening peri-engraftment respiratory distress syndrome in patients undergoing autologous stem cell transplantation.
    Bone Marrow Transplant. 2020 Dec 4. pii: 10.1038/s41409-020-01164.
    PubMed     Abstract available


  286. VAXMAN I, Visram A, Kumar S, Dispenzieri A, et al
    Autologous stem cell transplantation for multiple myeloma patients aged >/= 75 treated with novel agents.
    Bone Marrow Transplant. 2020 Dec 4. pii: 10.1038/s41409-020-01159.
    PubMed     Abstract available


  287. JABBOUR J, Manana B, Zahreddine A, Al-Shaar L, et al
    Vitamins and minerals intake adequacy in hematopoietic stem cell transplant: results of a randomized controlled trial.
    Bone Marrow Transplant. 2020 Dec 1. pii: 10.1038/s41409-020-01154.
    PubMed     Abstract available


    November 2020
  288. BERRO M, Rivas M, Trucco J, Paganini I, et al
    Post-transplant cyclophosphamide demonstrates lower non-relapse mortality and better graft-versus-host disease/relapse-free survival compared with antithymocyte globulin in unrelated donor hematopoietic stem cell transplantation. A single-center exper
    Bone Marrow Transplant. 2020 Nov 28. pii: 10.1038/s41409-020-01146.
    PubMed    


  289. PAVIGLIANITI A, Labopin M, Blaise D, Socie G, et al
    Comparison of mycophenolate mofetil and calcineurin inhibitor versus calcineurin inhibitor-based graft-versus-host-disease prophylaxis for matched unrelated donor transplant in acute myeloid leukemia. A study from the ALWP of the EBMT.
    Bone Marrow Transplant. 2020 Nov 28. pii: 10.1038/s41409-020-01155.
    PubMed     Abstract available


  290. OTTH M, Schindera C, Gungor T, Ansari M, et al
    Transplant characteristics and self-reported pulmonary outcomes in Swiss childhood cancer survivors after hematopoietic stem cell transplantation-a cohort study.
    Bone Marrow Transplant. 2020 Nov 25. pii: 10.1038/s41409-020-01137.
    PubMed     Abstract available


  291. HUA J, Zhang J, Zhang X, Wu X, et al
    Donor-derived anti-CD19 CAR T cells compared with donor lymphocyte infusion for recurrent B-ALL after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Nov 24. pii: 10.1038/s41409-020-01140.
    PubMed     Abstract available


  292. EBBESEN M, Weischendorff S, Kielsen K, Kammersgaard M, et al
    Insulin-like growth factor-I predicts sinusoidal obstruction syndrome following pediatric hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Nov 20. pii: 10.1038/s41409-020-01127.
    PubMed     Abstract available


  293. MENGLING T, Rall G, Bernas SN, Astreou N, et al
    Stem cell donor registry activities during the COVID-19 pandemic: a field report by DKMS.
    Bone Marrow Transplant. 2020 Nov 20. pii: 10.1038/s41409-020-01138.
    PubMed     Abstract available


  294. JENTZSCH M, Grimm J, Bill M, Brauer D, et al
    ELN risk stratification and outcomes in secondary and therapy-related AML patients consolidated with allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2020 Nov 19. pii: 10.1038/s41409-020-01129.
    PubMed     Abstract available


  295. VAXMAN I, Sidiqi MH, Al Saleh AS, Kumar S, et al
    Depth of response prior to autologous stem cell transplantation predicts survival in light chain amyloidosis.
    Bone Marrow Transplant. 2020 Nov 18. pii: 10.1038/s41409-020-01136.
    PubMed     Abstract available


  296. BLAGOV S, Zvyagin IV, Shelikhova L, Khismatullina R, et al
    T-cell tracking, safety, and effect of low-dose donor memory T-cell infusions after alphabeta T cell-depleted hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Nov 17. pii: 10.1038/s41409-020-01128.
    PubMed     Abstract available


  297. MAAS-BAUER K, Kiote-Schmidt C, Bertz H, Apostolova P, et al
    Ruxolitinib-ECP combination treatment for refractory severe chronic graft-versus-host disease.
    Bone Marrow Transplant. 2020 Nov 17. pii: 10.1038/s41409-020-01122.
    PubMed     Abstract available


  298. KANG HM, Kim SK, Lee JW, Chung NG, et al
    Efficacy of low dose antithymocyte globulin on overall survival, relapse rate, and infectious complications following allogeneic peripheral blood stem cell transplantation for leukemia in children.
    Bone Marrow Transplant. 2020 Nov 17. pii: 10.1038/s41409-020-01121.
    PubMed     Abstract available


  299. CASTAGNA L, Pagliardini T, Bramanti S, Schiano de Colella JM, et al
    Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome.
    Bone Marrow Transplant. 2020 Nov 15. pii: 10.1038/s41409-020-01133.
    PubMed     Abstract available


  300. MARCO-AYALA J, Gomez-Segui I, Sanz G, Solves P, et al
    Pure red cell aplasia after major or bidirectional ABO incompatible hematopoietic stem cell transplantation: to treat or not to treat, that is the question.
    Bone Marrow Transplant. 2020 Nov 14. pii: 10.1038/s41409-020-01124.
    PubMed     Abstract available


  301. KHAN M, Iftikhar R, Ghafoor T, Hussain F, et al
    Allogeneic hematopoietic stem cell transplant in rare hematologic disorders: a single center experience from Pakistan.
    Bone Marrow Transplant. 2020 Nov 12. pii: 10.1038/s41409-020-01126.
    PubMed     Abstract available


  302. GERTZ MA, Lacy MQ, Jacob EK, Hogan WJ, et al
    Use of autologous stem cells cryopreserved for over 15 years in stem cell transplantation for multiple myeloma.
    Bone Marrow Transplant. 2020 Nov 11. pii: 10.1038/s41409-020-01131.
    PubMed    


  303. SULTAN AM, Mahmoud HK, Fathy GM, Abdelfattah NM, et al
    The outcome of hematopoietic stem cell transplantation patients with COVID-19 infection.
    Bone Marrow Transplant. 2020 Nov 4. pii: 10.1038/s41409-020-01094.
    PubMed    


  304. BERSVENDSEN HS, Haugnes HS, Dahl AA, Fagerli UM, et al
    Sexual dysfunction is prevalent in female lymphoma survivors after autologous stem-cell transplantation and is associated with younger age, chronic fatigue, and mental distress.
    Bone Marrow Transplant. 2020 Nov 3. pii: 10.1038/s41409-020-01098.
    PubMed     Abstract available


  305. MORITA K, Fujiwara SI, Ikeda T, Kawaguchi SI, et al
    Identification of endoscopic factors that predict poor responses to steroids in patients with gastrointestinal acute graft-versus-host disease.
    Bone Marrow Transplant. 2020 Nov 2. pii: 10.1038/s41409-020-01096.
    PubMed     Abstract available


    October 2020
  306. IWAMOTO M, Ikegawa S, Kondo T, Meguri Y, et al
    Post-transplantation cyclophosphamide restores early B-cell lymphogenesis that suppresses subsequent chronic graft-versus-host disease.
    Bone Marrow Transplant. 2020 Oct 30. pii: 10.1038/s41409-020-01100.
    PubMed    


  307. YOON JH, Min GJ, Park SS, Park S, et al
    Impact of donor type on long-term graft-versus-host disease-free/relapse-free survival for adult acute lymphoblastic leukemia in first remission.
    Bone Marrow Transplant. 2020 Oct 30. pii: 10.1038/s41409-020-01097.
    PubMed     Abstract available


  308. IRENE GC, Albert E, Anna BV, Rahinatu A, et al
    Patterns of infection and infectious-related mortality in patients receiving post-transplant high dose cyclophosphamide as graft-versus-host-disease prophylaxis: impact of HLA donor matching.
    Bone Marrow Transplant. 2020 Oct 26. pii: 10.1038/s41409-020-01092.
    PubMed     Abstract available


  309. EL-SERAFI A, He R, Zheng W, Benkossou F, et al
    Vitamin D levels and busulphan kinetics in patients undergoing hematopoietic stem cell transplantation, a multicenter study.
    Bone Marrow Transplant. 2020 Oct 21. pii: 10.1038/s41409-020-01091.
    PubMed     Abstract available


  310. WATERHOUSE M, Pennisi S, Pfeifer D, Deuter M, et al
    Colon and liver tissue damage detection using methylated SESN3 and PTK2B genes in circulating cell-free DNA in patients with acute graft-versus-host disease.
    Bone Marrow Transplant. 2020 Oct 20. pii: 10.1038/s41409-020-01090.
    PubMed     Abstract available


  311. MODI D, Kim S, Deol A, Ayash L, et al
    Comparison of myeloablative and reduced intensity conditioning regimens in haploidentical peripheral blood stem cell transplantation.
    Bone Marrow Transplant. 2020 Oct 16. pii: 10.1038/s41409-020-01079.
    PubMed     Abstract available


  312. BENTO L, Boumendil A, Finel H, Khvedelidze I, et al
    Tandem autologous-reduced intensity allogeneic stem cell transplantation in high-risk relapsed Hodgkin lymphoma: a retrospective study of the Lymphoma Working Party-EBMT.
    Bone Marrow Transplant. 2020 Oct 12. pii: 10.1038/s41409-020-01075.
    PubMed     Abstract available


  313. KEKRE N, Kim HT, Hofer J, Ho VT, et al
    Correction: Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease.
    Bone Marrow Transplant. 2020 Oct 12. pii: 10.1038/s41409-020-01083.
    PubMed     Abstract available


  314. MORISHIMA S, Fukuda T, Doki N, Mori T, et al
    Individual HLAs influence immunological events in allogeneic stem cell transplantation from HLA-identical sibling donors.
    Bone Marrow Transplant. 2020 Oct 9. pii: 10.1038/s41409-020-01070.
    PubMed     Abstract available


  315. HOLIG K, Schmidt H, Hutter G, Kramer M, et al
    Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial.
    Bone Marrow Transplant. 2020 Oct 7. pii: 10.1038/s41409-020-01053.
    PubMed     Abstract available


  316. LOKE J, Labopin M, Craddock C, Niederwieser D, et al
    Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT.
    Bone Marrow Transplant. 2020 Oct 2. pii: 10.1038/s41409-020-01072.
    PubMed     Abstract available


  317. SCHETELIG J, Chevallier P, van Gelder M, Hoek J, et al
    Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party.
    Bone Marrow Transplant. 2020 Oct 2. pii: 10.1038/s41409-020-01069.
    PubMed     Abstract available


    September 2020
  318. SUGITA J, Kamimura T, Ishikawa T, Ota S, et al
    Reduced dose of posttransplant cyclophosphamide in HLA-haploidentical peripheral blood stem cell transplantation.
    Bone Marrow Transplant. 2020 Sep 24. pii: 10.1038/s41409-020-01065.
    PubMed     Abstract available


  319. MAAKARON JE, McKenna D Jr, El-Jurdi N, Arora M, et al
    COVID19 seroconversion in an unrelated stem cell donor.
    Bone Marrow Transplant. 2020 Sep 22. pii: 10.1038/s41409-020-01066.
    PubMed    


  320. KOYAMAISHI S, Kamio T, Kobayashi A, Sato T, et al
    Reduced-intensity conditioning is effective for hematopoietic stem cell transplantation in young pediatric patients with Diamond-Blackfan anemia.
    Bone Marrow Transplant. 2020 Sep 18. pii: 10.1038/s41409-020-01056.
    PubMed     Abstract available


  321. SALEH W, Katz J
    Periodontal diseases, caries, and dental abscesses prevalence in hematopoietic stem cell transplant recipients.
    Bone Marrow Transplant. 2020 Sep 18. pii: 10.1038/s41409-020-01057.
    PubMed    


    May 2020
  322. OLRY DE LABRY LIMA A, Matas Hoces A, Gimeno Ballester V, Rios Sanchez E, et al
    Cost-effectiveness of lenalidomide.
    Bone Marrow Transplant. 2020;55:853-854.
    PubMed    


  323. DHANASIRI S
    Response to: Olry de Labry Lima A et al., Cost-effectiveness of lenalidomide maintenance in patients with multiple myeloma who have undergone autologous transplant hematopoietic progenitor cells.
    Bone Marrow Transplant. 2020;55:987-988.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Stem Cell Research is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: